Skip to main content
OpenTrials

Clinical trial condition

Coagulation Protein Disorders

Explore clinical trials studying Coagulation Protein Disorders. Study availability and eligibility vary by location and protocol.

784 public trials 106 recruiting studies
Refine in advanced search Browse all conditions

Coagulation Protein Disorders trial results

Not Yet Recruiting

Study of Efficacy and Safety of FRSW107 in Pediatric Patients With Severe Hemophilia A

NCT06136507

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Children's Hospital Affiliated to Chongqing Medical University Chongqing, China
  • Guangzhou Women and Children Medical Center Guangzhou, China
  • Nanfang Hospital, Southern Medical University Guangzhou, China
  • Affiliated Hospital of Guizhou Medical University Guizhou, China
View all 13 locations
View Trial Details
Completed

Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Chinese Subjects With Hemophilia B Previously Treated With FIX Therapy

NCT06399289

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Beijing Children's Hospital Beijing, Beijing Municipality, China
  • Union Hospital Affiliated to Fujian Medical University Fuzhou, Fujian, China
  • Nanfang Hospital of Southern Medical University Guangzhou, Guangdong, China
  • Affiliated Hospital of Guizhou Medical University Guiyang, Guizhou, China
View Trial Details
Completed

ATHN 9: Severe VWD Natural History Study

NCT03853486

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Blood Platelet Disorders, +8 more
Locations
  • Center for Inherited Blood Disorders Orange, California, United States
  • University of Colorado Denver Hemophilia and Thrombosis Center Aurora, Colorado, United States
  • Connecticut Bleeding and Clotting Disorders Center Farmington, Connecticut, United States
  • University of Florida Hemophilia Treatment Center Gainesville, Florida, United States
View all 22 locations
View Trial Details
Completed

A Study to Learn How Safe the Study Treatment BAY94-9027 is and How it Affects the Body in Previously Treated Children Aged 7 to Less Than 12 Years With Severe Hemophilia A, a Genetic Bleeding Disorder That is Caused by the Lack of a Protein Called Clotting Factor 8 (FVIII) in the Blood

NCT05147662

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Children, +9 more
Locations
  • Arnold Palmer Hospital for Children Orlando, Florida, United States
  • Hospital de Niños Sor María Ludovica La Plata, Buenos Aires, Argentina
  • Instituo Hematología Arbesú Godoy Cruz, Mendoza Province, Argentina
  • Instituto de Hematología Dr. Rubén Dávoli Rosario, Santa Fe Province, Argentina
View all 18 locations
View Trial Details

Related conditions